Back to search
Atherosclerosis Cardiovascular Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Atherosclerosis Cardiovascular Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Atherosclerosis Cardiovascular Disease trials you may qualify forThe goal of this double-blind randomized controlled trial is to determine how treatment with high intensity statin, low-dose colchicine, and their combination m…
The Primary Objective is to determine if a new nuclear tracer (named 18F-Florbetaben) used with nuclear imaging (PET imaging) can detect inflamed plaque in pati…
The objective of this registry is to collect observational data under local standard of care and evaluate safety and performance of the Serranator® in treatment…
The PROVE Trial is a randomized clinical trial that will determine whether a weight loss intervention combined with walking exercise achieves greater improvemen…
This study will evaluate people with dyslipidemias - disorders that affect the fat content in the blood. Fats, or lipids, such as cholesterol and triglycerides,…
This study is an investigator-initiated, prospective, single-center, 1:1 randomized pilot study. The trial evaluates the safety and efficacy of intravascular l…
This is a study to evaluate the efficacy and safety of AZD0780 in adults with clinical ASCVD or who are at risk for a first ASCVD event and who have elevated LD…
Upper limb arterial disease is a rare condition compared to lower limb arterial disease. In the lower limb, chronic limb ischemia (CLI) is characterized by an i…
The objective of this first-in-human study is to assess the safety and effectiveness of the Serranator Sonic Intravascular Lithotripsy (IVL) System™ for the tre…